Please enable JavaScript to continue using this application.

Compare $BNTC vs $CABA | Chartloom

Compare

$BNTC vs $CABA

Benitec Biopharma Inc · Cabaletta Bio Inc

BNTC

Benitec Biopharma Inc

CABA

Cabaletta Bio Inc

Compare $BNTC vs $CABA

Comparing Benitec Biopharma Inc and Cabaletta Bio Inc

BNTCBenitec Biopharma Inc

CABACabaletta Bio Inc

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

CABACabaletta Bio Inc

Market cap

$315M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-12.7%

52W performance

-19.9%

FCF yield

-49.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BNTC

CABA

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

CABA

Cabaletta Bio Inc

Market Cap

BNTC$305M

CABA$315M

Enterprise Value

BNTC$125M

CABA$110M

Price

BNTC$8.87

CABA$1.93

P/E Ratio

BNTCN/A

CABAN/A

P/S Ratio

BNTC4,474.96x

CABA0.00x

EV/Sales

BNTC1,903.93x

CABA0.00x

EV/EBITDA

BNTC0.00x

CABA0.00x

P/B Ratio

BNTC1.77x

CABA1.61x

P/FCF Ratio

BNTCN/A

CABAN/A

EV/FCF

BNTC-7.50x

CABA-0.71x

PEG Ratio

BNTCN/A

CABAN/A

Forward P/E (NTM)

BNTCN/A

CABAN/A

Forward P/S (NTM)

BNTCN/A

CABAN/A

Revenue (TTM)

BNTC$0

CABA$0

Revenue Growth (YoY)

BNTCN/A

CABAN/A

Forward Rev Growth

BNTC13.8%

CABA452.2%

Gross Margin (TTM)

BNTC100.0%

CABA0.0%

Operating Margin (TTM)

BNTC0.0%

CABA0.0%

EBITDA Margin (TTM)

BNTC0.0%

CABA0.0%

Net Margin (TTM)

BNTC0.0%

CABA0.0%

FCF Margin (TTM)

BNTCN/A

CABAN/A

Net Income (TTM)

BNTC$-33M

CABA$-181M

FCF (TTM)

BNTC$-17M

CABA$-154M

EPS (TTM)

BNTC$0.00

CABA-$1.20

ROE (TTM)

BNTC-3482.0%

CABA-12827.0%

ROA (TTM)

BNTC-3411.0%

CABA-9547.0%

ROIC (TTM)

BNTC-3482.0%

CABA-11070.0%

Cash

BNTC$180M

CABA$225M

Debt

BNTC$0

CABA$20M

Net Cash/Debt

BNTC$180M

CABA$205M

Current Ratio (TTM)

BNTC34.00x

CABA5.79x

Quick Ratio (TTM)

BNTC33.70x

CABA5.64x

Debt/Equity (TTM)

BNTC0.00x

CABA0.09x

Debt/Assets (TTM)

BNTC0.0%

CABA0.0%

Interest Coverage (TTM)

BNTCN/A

CABAN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

CABA0.00x

Beta

BNTC0.23

CABA3.54

52W Performance

BNTC-37.1%

CABA-19.9%

YTD Performance

BNTC-29.5%

CABA-12.7%

% from 52W High

BNTC-47.1%

CABA-54.4%

% from 52W Low

BNTC4.1%

CABA5.5%

Asset Turnover (TTM)

BNTC0.01x

CABA0.00x

FCF Yield (TTM)

BNTC-5.5%

CABA-49.0%

Earnings Yield (TTM)

BNTC-10.7%

CABA-57.6%

Dividend Yield (TTM)

BNTCN/A

CABAN/A

Rule of 40

BNTC0.0

CABA0.0

EV/GP/RG

BNTCN/A

CABAN/A

Ticker research

View BNTC research View CABA research

Metric	BNTC Benitec Biopharma Inc	CABA Cabaletta Bio Inc
Market & Valuation
Market Cap	$305M	$315M
Enterprise Value	$125M	$110M
Price	$8.87	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.77x	1.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	452.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-181M
FCF (TTM)	$-17M	$-154M
EPS (TTM)	$0.00	-$1.20
ROE (TTM)	-3482.0%	-12827.0%
ROA (TTM)	-3411.0%	-9547.0%
ROIC (TTM)	-3482.0%	-11070.0%
Financial Health
Cash	$180M	$225M
Debt	$0	$20M
Net Cash/Debt	$180M	$205M
Current Ratio (TTM)	34.00x	5.79x
Quick Ratio (TTM)	33.70x	5.64x
Debt/Equity (TTM)	0.00x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	3.54
52W Performance	-37.1%	-19.9%
YTD Performance	-29.5%	-12.7%
% from 52W High	-47.1%	-54.4%
% from 52W Low	4.1%	5.5%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-49.0%
Earnings Yield (TTM)	-10.7%	-57.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View CABA research

Valuation

P/S Ratio

CABA

0.00x

BNTC

4,474.96x

EV/FCF

BNTC

-7.50x

CABA

-0.71x

Growth & revenue

Forward Revenue Growth

CABA

452.2%

BNTC

13.8%

Profitability & performance

Gross Margin

BNTC

100.0%

CABA

0.0%

ROE

BNTC

-3482.0%

CABA

-12827.0%

FCF Yield %

BNTC

-5.5%

CABA

-49.0%

52-Week Performance

CABA

-19.9%

BNTC

-37.1%

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

CABA

Cabaletta Bio Inc

Market Cap

BNTC$305M

CABA$315M

Enterprise Value

BNTC$125M

CABA$110M

Price

BNTC$8.87

CABA$1.93

P/E Ratio

BNTCN/A

CABAN/A

P/S Ratio

BNTC4,474.96x

CABA0.00x

EV/Sales

BNTC1,903.93x

CABA0.00x

EV/EBITDA

BNTC0.00x

CABA0.00x

P/B Ratio

BNTC1.77x

CABA1.61x

P/FCF Ratio

BNTCN/A

CABAN/A

EV/FCF

BNTC-7.50x

CABA-0.71x

PEG Ratio

BNTCN/A

CABAN/A

Forward P/E (NTM)

BNTCN/A

CABAN/A

Forward P/S (NTM)

BNTCN/A

CABAN/A

Revenue (TTM)

BNTC$0

CABA$0

Revenue Growth (YoY)

BNTCN/A

CABAN/A

Forward Rev Growth

BNTC13.8%

CABA452.2%

Gross Margin (TTM)

BNTC100.0%

CABA0.0%

Operating Margin (TTM)

BNTC0.0%

CABA0.0%

EBITDA Margin (TTM)

BNTC0.0%

CABA0.0%

Net Margin (TTM)

BNTC0.0%

CABA0.0%

FCF Margin (TTM)

BNTCN/A

CABAN/A

Net Income (TTM)

BNTC$-33M

CABA$-181M

FCF (TTM)

BNTC$-17M

CABA$-154M

EPS (TTM)

BNTC$0.00

CABA-$1.20

ROE (TTM)

BNTC-3482.0%

CABA-12827.0%

ROA (TTM)

BNTC-3411.0%

CABA-9547.0%

ROIC (TTM)

BNTC-3482.0%

CABA-11070.0%

Cash

BNTC$180M

CABA$225M

Debt

BNTC$0

CABA$20M

Net Cash/Debt

BNTC$180M

CABA$205M

Current Ratio (TTM)

BNTC34.00x

CABA5.79x

Quick Ratio (TTM)

BNTC33.70x

CABA5.64x

Debt/Equity (TTM)

BNTC0.00x

CABA0.09x

Debt/Assets (TTM)

BNTC0.0%

CABA0.0%

Interest Coverage (TTM)

BNTCN/A

CABAN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

CABA0.00x

Beta

BNTC0.23

CABA3.54

52W Performance

BNTC-37.1%

CABA-19.9%

YTD Performance

BNTC-29.5%

CABA-12.7%

% from 52W High

BNTC-47.1%

CABA-54.4%

% from 52W Low

BNTC4.1%

CABA5.5%

Asset Turnover (TTM)

BNTC0.01x

CABA0.00x

FCF Yield (TTM)

BNTC-5.5%

CABA-49.0%

Earnings Yield (TTM)

BNTC-10.7%

CABA-57.6%

Dividend Yield (TTM)

BNTCN/A

CABAN/A

Rule of 40

BNTC0.0

CABA0.0

EV/GP/RG

BNTCN/A

CABAN/A

Ticker research

View BNTC research View CABA research

Metric	BNTC Benitec Biopharma Inc	CABA Cabaletta Bio Inc
Market & Valuation
Market Cap	$305M	$315M
Enterprise Value	$125M	$110M
Price	$8.87	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.77x	1.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	452.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-181M
FCF (TTM)	$-17M	$-154M
EPS (TTM)	$0.00	-$1.20
ROE (TTM)	-3482.0%	-12827.0%
ROA (TTM)	-3411.0%	-9547.0%
ROIC (TTM)	-3482.0%	-11070.0%
Financial Health
Cash	$180M	$225M
Debt	$0	$20M
Net Cash/Debt	$180M	$205M
Current Ratio (TTM)	34.00x	5.79x
Quick Ratio (TTM)	33.70x	5.64x
Debt/Equity (TTM)	0.00x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	3.54
52W Performance	-37.1%	-19.9%
YTD Performance	-29.5%	-12.7%
% from 52W High	-47.1%	-54.4%
% from 52W Low	4.1%	5.5%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-49.0%
Earnings Yield (TTM)	-10.7%	-57.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View CABA research